By Meghan Geary, COO, MedX Health

Over the last several months, I have had the unusual experience of becoming both a student and a test subject.

As part of my role at MedX, I have spent countless hours learning about skin biology, evaluating technologies, reviewing research, and speaking with scientists, clinicians, researchers, and skincare experts. Along the way, I have also tested more products, treatments, devices, and protocols than I can remember.

Skin health is being redefined. It is no longer viewed as a static surface, but as a dynamic biological system shaped by microbes, barrier function, inflammation, pigmentation, vascular activity, and environmental exposure. This shift has been driven in large part by advances in microbiome science, which have brought new visibility to the living ecosystem on the skin.

May is Skin Cancer Awareness Month, a time dedicated to education, prevention, and early detection of the most common cancer in the United States.

Beneath the skin’s surface is a complex biological system that traditional imaging doesn’t fully capture. At the center of that system are chromophores.

For decades, skin health has been defined by what we can see.

The Future of MedX Through the Lens of Dr. Paul Matts

Today, we’re sharing an update on how we’re continuing to build around a simple idea: skin health should be measurable, objective, and grounded in data — reflected in our newly rebranded website.